1. Практические рекомендации Всемирной Гастроэнтерологической Организации. Воспалительная болезнь кишечника: глобальные перспективы. Июнь 2009.
2. Адлер Г. Болезнь Крона и язвенный колит. Пер. с нем. А.А.Шептулина. М.: ГЭОТАР-МЕД, 2001.
3. Vermeire S, Van Assche G, Rutgeerts P. Role of genetics in prediction of disease course and response to therapy. World J Gastroenterol 2010; 16 (21): 2609–15.
4. Dubinsky MC. Serologic and laboratory markers in prediction of the disease course in inflammatory bowel disease. World J Gastroenterol 2010; 16 (21): 2604–8.
5. Fefferman DS, Farrell RJ. Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practice. Clin Gastroenterol Hepatol 2005; 3: 11–24.
6. Bentley E, Jenkins D, Campbell F, Warren B. How could pathologists improve the initial diagnosis of colitis? Evidence from an international workshop J Clin Pathol 2002; 55: 955–60.
7. Le Berre N, Heresbach D, Kerbaol M et al. Histological discrimination of idiopathic inflammatory bowel disease from other types of colitis. J Clin Pathol 1995; 48: 749–53.
8. Baumgart Daniel C. The Diagnosis and Treatment of Crohn's Disease and Ulcerative Colitis Deutsches Arzteblatt International Dtsch Arztebl Int 2009; 106 (8): 123–33.
9. Stange EF, Travis SP, Vermeire S et al. European evidence-based Consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006; 55 (Suppl. 1): i1–15.
10. Stange EF, Travis SPL, Vermeire S et al. European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. J Crohn's Colitis 2008; 2: 1–23.
11. Халиф И.Л. Воспалительные заболевания кишечника (неспецифический язвенный колит и болезнь Крона): клиника, диагностика и лечение. М.: Миклош, 2008.
12. Hanauer SB. Positioning biologic agents in the treatment of Crohn's disease. Inflamm Bowel Dis 2009; 15: 1570–82.
Авторы
М.А.Ливзан, М.А.Макейкина
Курс гастроэнтерологии последипломного образования ГОУ ВПО Омской государственной медицинской академии